ClinicalTrialsFinder

Upper Tract Urothelial Carcinoma Clinical Trials in Tianjin, Outside U.S.

1 recruitingTianjin, Outside U.S., China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Neoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUC

Neoadjuvant TherapyPD-1 InhibitorUpper Tract Urothelial Carcinoma+1 more
Tianjin Medical University Second Hospital35 enrolled1 locationNCT07126119